• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Moves Lower; Accenture Shares Tumble After Q2 Results

    3/21/24 3:03:36 PM ET
    $ACN
    $APYX
    $CURI
    $LU
    Real Estate
    Real Estate
    Medical/Dental Instruments
    Health Care
    Get the next $ACN alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday.

    The Dow traded up 0.77% to 39,814.95 while the NASDAQ rose 0.25% to 16,410.54. The S&P 500 also rose, gaining, 0.38% to 5,244.72.

    Check This Out: Micron, Accenture And 3 Stocks To Watch Heading Into Thursday

     

    Leading and Lagging Sectors

     

    Industrials shares jumped by 1% on Thursday.

    In trading on Thursday, materials shares rose by just 0.1%.

     

    Top Headline

     

    Shares of Accenture Plc (NYSE:ACN) dipped around 9% on Thursday after the company reported results for its fiscal second quarter.

    Accenture reported second-quarter fiscal 2024 sales of $15.80 billion compared with the consensus of $15.84 billion, flat Y/Y in U.S. dollars and local currency. Revenues were slightly above the midpoint of the company’s guided range of $15.40 billion – $16.00 billion. Adjusted EPS of $2.77 beat the consensus of $2.66.

    Accenture expects fiscal 2024 adjusted EPS of $11.97 – $12.20 (prior $11.97 – $12.32) versus consensus of $12.24. For fiscal 2024, the company expects revenue growth of 1% – 3% (prior 2% – 5%) in local currency vs. $66.18 billion consensus.

     

    Equities Trading UP

     

    Yield10 Bioscience, Inc. (NASDAQ:YTEN) shares shot up 70% to $0.4124 after the company announced that the USDA-APHIS Biotechnology Regulatory Services determined that the Camelina sativa varieties may be planted and bred in the United States.

    Shares of CuriosityStream Inc. (NASDAQ:CURI) got a boost, surging 56% to $0.91 after the company reported financial results for fourth quarter.

    Lufax Holding Ltd (NYSE:LU) shares were also up, gaining 40% to $4.7312 following fourth-quarter results.

     

    Equities Trading DOWN

     

    Movella Holdings Inc. (NASDAQ:MVLA) shares dropped 64% to $0.1039 after the company announced that it will voluntarily delist from the Nasdaq.

    Shares of Apyx Medical Corporation (NASDAQ:APYX) were down 26% to $1.36 following soft FY24 guidance.

    Spire Global, Inc. (NYSE:SPIR) was down, falling 34% to $11.54 after the company announced a $30 million registered direct offering of 2,142,858 shares at $14.00 per share.

    Also Check This Out: Alphabet, Jabil And 2 Other Stocks Insiders Are Selling

     

    Commodities

     

    In commodity news, oil traded down 0.6% to $80.82 while gold traded up 1% at $2,182.70.

    Silver traded down 0.5% to $24.99 on Thursday, while copper rose 0.2% to $4.0605.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 gained 0.90%, London’s FTSE 100 jumped 1.88% while Spain’s IBEX 35 Index rose 1.07% The German DAX rose 0.91% French CAC 40 rose 0.22% while Italy’s FTSE MIB Index gained 0.10%.

    The HCOB Eurozone manufacturing PMI declined to a three-month low level of 45.7 in March, while services PMI increased to 51.1 from 50.2. The Eurozone posted a current account surplus of €24.87 billion in January versus a year-ago deficit of €11.9 billion. Passenger car registrations in the European Union surged 10.1% year-over-year to 883.6 thousand units for February.

    The HCOB Germany composite PMI climbed to 47.4 in March from 46.3 a month ago, while French composite PMI declined to 47.7 in March from 48.1 in February. The S&P Global UK services PMI fell to 53.4 in March from 53.8 in the previous month, while manufacturing PMI climbed to 49.9 in March from 47.5.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Thursday, with Japan’s Nikkei 225 surging 2.03%, Hong Kong’s Hang Seng Index rising 1.93%, China’s Shanghai Composite Index falling 0.08% and India’s S&P BSE Sensex gaining 0.75%.

    The annual inflation rate in Hong Kong accelerated to 2.1% in February from January’s reading of 1.7%. Hong Kong's current account surplus increased to HKD 71.2 billion in the fourth quarter from HKD 55.9 billion in the year-ago period. The Hong Kong Monetary Authority kept its base rate unchanged at 5.75%.

    The HSBC Flash India composite PMI increased to 61.4 in March versus a final reading of 60.6. The au Jibun Bank Japan composite PMI surged to 52.3 in March versus a final reading of 50.6 in February. Japan's trade deficit narrowed to JPY 379,358 billion in February from JPY 928.908 billion in the year-ago period.

     

    Economics

     

    The Philadelphia Fed Manufacturing Index in fell to 3.2 in March from 5.2 in the previous month.

    U.S. initial jobless claims declined by 2,000 to 210,000 on the week ending March 16, versus market estimates of 215,000.

    The U.S. current account deficit shrank by $1.6 billion to $194.8 billion during the fourth quarter, compared to market estimates for a $209 billion gap.

    The S&P Global services PMI declined to a three-month low level of 51.7 in March from 52.3 in the previous month.

    The S&P Global manufacturing PMI climbed to a 21-month high level of 52.5 in March from 52.2 a month ago.

    U.S. existing-home sales jumped 9.5% to an annualized rate of 4.38 million units in February.

    Now Read This: Top 3 Tech Stocks That Could Lead To Your Biggest Gains In March

    Get the next $ACN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACN
    $APYX
    $CURI
    $LU

    CompanyDatePrice TargetRatingAnalyst
    Accenture plc
    $ACN
    2/17/2026$275.00Equal Weight → Overweight
    Wells Fargo
    Accenture plc
    $ACN
    1/22/2026$313.00Buy
    Berenberg
    Spire Global Inc.
    $SPIR
    1/6/2026$14.00Buy
    H.C. Wainwright
    Accenture plc
    $ACN
    1/6/2026$317.00Buy
    Truist
    Spire Global Inc.
    $SPIR
    12/24/2025Buy → Neutral
    Alliance Global Partners
    Apyx Medical Corporation
    $APYX
    12/16/2025$6.00Buy
    Roth Capital
    Accenture plc
    $ACN
    12/16/2025$320.00Equal-Weight → Overweight
    Morgan Stanley
    Apyx Medical Corporation
    $APYX
    11/14/2025Mkt Perform → Mkt Outperform
    Citizens JMP
    More analyst ratings

    $ACN
    $APYX
    $CURI
    $LU
    SEC Filings

    View All

    SEC Form 10-K filed by Apyx Medical Corporation

    10-K - Apyx Medical Corp (0000719135) (Filer)

    3/10/26 1:11:10 PM ET
    $APYX
    Medical/Dental Instruments
    Health Care

    Apyx Medical Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Apyx Medical Corp (0000719135) (Filer)

    3/10/26 7:01:32 AM ET
    $APYX
    Medical/Dental Instruments
    Health Care

    SEC Form 6-K filed by Lufax Holding Ltd

    6-K - Lufax Holding Ltd (0001816007) (Filer)

    3/5/26 9:01:18 AM ET
    $LU
    Finance: Consumer Services
    Finance

    $ACN
    $APYX
    $CURI
    $LU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Burgum Melissa A was granted 94 units of Class A ordinary shares, increasing direct ownership by 1% to 8,230 units (SEC Form 4)

    4 - Accenture plc (0001467373) (Issuer)

    3/9/26 9:18:18 AM ET
    $ACN
    Real Estate

    CEO-The Americas Walsh John F was granted 129 units of Class A ordinary shares, increasing direct ownership by 0.51% to 25,250 units (SEC Form 4)

    4 - Accenture plc (0001467373) (Issuer)

    3/9/26 9:18:12 AM ET
    $ACN
    Real Estate

    Chief Operating Officer Hogan Catherine Kiernan was granted 101 units of Class A ordinary shares, increasing direct ownership by 0.79% to 12,919 units (SEC Form 4)

    4 - Accenture plc (0001467373) (Issuer)

    3/9/26 9:18:01 AM ET
    $ACN
    Real Estate

    $ACN
    $APYX
    $CURI
    $LU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Hill Matthew C bought $6,780 worth of shares (6,000 units at $1.13), increasing direct ownership by 240% to 8,500 units (SEC Form 4)

    4/A - Apyx Medical Corp (0000719135) (Issuer)

    3/3/25 4:05:12 PM ET
    $APYX
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Hayden Phillip Brady bought $5,030 worth of shares (3,000 units at $1.68) (SEC Form 4)

    4 - CuriosityStream Inc. (0001776909) (Issuer)

    12/16/24 3:00:45 PM ET
    $CURI
    Movies/Entertainment
    Consumer Discretionary

    President and CEO Stinchcomb Clinton Larry bought $29,998 worth of shares (17,877 units at $1.68), increasing direct ownership by 0.84% to 2,155,306 units (SEC Form 4)

    4 - CuriosityStream Inc. (0001776909) (Issuer)

    12/16/24 2:59:34 PM ET
    $CURI
    Movies/Entertainment
    Consumer Discretionary

    $ACN
    $APYX
    $CURI
    $LU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Accenture upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Accenture from Equal Weight to Overweight and set a new price target of $275.00

    2/17/26 8:01:23 AM ET
    $ACN
    Real Estate

    Berenberg initiated coverage on Accenture with a new price target

    Berenberg initiated coverage of Accenture with a rating of Buy and set a new price target of $313.00

    1/22/26 8:28:24 AM ET
    $ACN
    Real Estate

    H.C. Wainwright initiated coverage on Spire Global with a new price target

    H.C. Wainwright initiated coverage of Spire Global with a rating of Buy and set a new price target of $14.00

    1/6/26 8:58:32 AM ET
    $SPIR
    Telecommunications Equipment
    Consumer Discretionary

    $ACN
    $APYX
    $CURI
    $LU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

    Reported record total revenue of $19.2 million in the fourth quarter of 2025Scaling U.S. commercial launch of AYON Body Contouring System™ (AYON) to meet strong market demandExpect FY2026 total revenue in the range of $57.5 million to $58.5 millionManagement to host a conference call today at 8:00 a.m. ET CLEARWATER, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its fourth quarter and full year ended December 31, 2025. Recent Financial and Operating Highlights: Reported

    3/10/26 7:00:00 AM ET
    $APYX
    Medical/Dental Instruments
    Health Care

    Ten Spire Global Satellites Arrive at Launch Site Ahead of Upcoming Launch

    Second launch of 2026 highlights manufacturing cadence and industrial scale of Spire's vertically integrated satellite platform All satellites were designed, built, integrated, and tested in-house to support diverse government and commercial missions Spire Global, Inc. (NYSE:SPIR) ("Spire" or "the Company"), a leading global provider of satellite data, analytics and intelligence, announced that all ten of its multipurpose satellites, integrated via Germany's launch integrator Exolaunch, have arrived at Vandenberg Space Force Base in California ahead of their upcoming launch aboard the Transporter-16 rideshare mission with SpaceX. The satellites will support a mix of customer missio

    3/5/26 6:45:00 AM ET
    $SPIR
    Telecommunications Equipment
    Consumer Discretionary

    Spire Global Schedules Fourth Quarter and Full Year 2025 Results Conference Call

    Spire Global, Inc. (NYSE:SPIR) ("Spire" or "the Company"), a global provider of space-based data, analytics and space services, will hold a conference call with investors and analysts on Wednesday, March 18, 2026 at 8:30 a.m. ET to discuss the Company's fourth quarter and full year 2025 financial results. The news release announcing the results will be disseminated before the call. A live webcast of the conference call will be available on Spire Global's Investor Relations website at ir.spire.com. The toll-free dial-in number for the live audio call is 877-841-2968. The conference ID for the call is 13759021. A replay of the webcast will be available for six months at ir.spire.com. Abou

    3/4/26 4:56:00 PM ET
    $SPIR
    Telecommunications Equipment
    Consumer Discretionary

    $ACN
    $APYX
    $CURI
    $LU
    Leadership Updates

    Live Leadership Updates

    View All

    Accenture Appoints Rachel Frey Chief Communications Officer

    Accenture (NYSE:ACN) today announced the appointment of Rachel Frey as chief communications officer, a newly created role. Effective immediately, Frey reports to Accenture Chair and CEO Julie Sweet and joins Accenture's Global Management Committee. Frey brings more than two decades of experience in communications. In her most recent role as Accenture's global head of Corporate Communications, she strengthened the company's relationships with external audiences; developed and elevated an enhanced earned communications strategy that has strategically positioned Accenture and its leaders at the forefront of AI reinvention across every major sector and region around the world; and leveraged d

    2/11/26 10:43:00 AM ET
    $ACN
    Real Estate

    CuriosityStream Names John Higgins Vice President, Content Partnerships, to Accelerate Growth in AI Licensing and Strategic Alliances

    CuriosityStream Inc. (NASDAQ:CURI), a global leader in factual entertainment, today announced the appointment of John Higgins as Vice President, Content Partnerships. In this expanded role, Higgins is focusing on building and deepening the company's fast-growing licensing relationships with major technology and AI Developer partners. He reports directly to Clint Stinchcomb, President and Chief Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251106643709/en/CuriosityStream appoints John Higgins as Vice President of Content Partnerships. "John has been a driving force in helping CuriosityStream engage with a new c

    11/6/25 1:00:00 PM ET
    $CURI
    Movies/Entertainment
    Consumer Discretionary

    Lufax Announces New Senior Management Hire

    SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Lufax Holding Ltd (NYSE:LU), a leading financial services enabler for small business owners in China, today announced that it has appointed Mr. Xiang Ji as the Co-Chief Executive Officer of the Company and Mr. Tao Wu as the Executive Deputy General Manager and Chief Marketing Officer of the Company, with immediate effect. The biographical details of Mr. Ji and Mr. Wu are set out below. Mr. Xiang Ji, aged 43, possesses close to 20 years of cross-industry work experience in retail credit, risk management and investment management. Mr. Ji served at McKinsey & Consulting Company Inc. from February 2014 to September 2025, with his last position as Global M

    10/31/25 7:11:00 AM ET
    $LU
    Finance: Consumer Services
    Finance

    $ACN
    $APYX
    $CURI
    $LU
    Financials

    Live finance-specific insights

    View All

    Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

    Reported record total revenue of $19.2 million in the fourth quarter of 2025Scaling U.S. commercial launch of AYON Body Contouring System™ (AYON) to meet strong market demandExpect FY2026 total revenue in the range of $57.5 million to $58.5 millionManagement to host a conference call today at 8:00 a.m. ET CLEARWATER, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its fourth quarter and full year ended December 31, 2025. Recent Financial and Operating Highlights: Reported

    3/10/26 7:00:00 AM ET
    $APYX
    Medical/Dental Instruments
    Health Care

    Spire Global Schedules Fourth Quarter and Full Year 2025 Results Conference Call

    Spire Global, Inc. (NYSE:SPIR) ("Spire" or "the Company"), a global provider of space-based data, analytics and space services, will hold a conference call with investors and analysts on Wednesday, March 18, 2026 at 8:30 a.m. ET to discuss the Company's fourth quarter and full year 2025 financial results. The news release announcing the results will be disseminated before the call. A live webcast of the conference call will be available on Spire Global's Investor Relations website at ir.spire.com. The toll-free dial-in number for the live audio call is 877-841-2968. The conference ID for the call is 13759021. A replay of the webcast will be available for six months at ir.spire.com. Abou

    3/4/26 4:56:00 PM ET
    $SPIR
    Telecommunications Equipment
    Consumer Discretionary

    Accenture to Announce Second-Quarter Fiscal 2026 Results

    Accenture Schedules Second-Quarter Fiscal 2026 Earnings Call Accenture (NYSE:ACN) will host a conference call at 8:00 a.m. EDT on Thursday, March 19, 2026, to discuss its second-quarter fiscal 2026 financial results. An earnings news release will be issued before the call. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303434979/en/ To participate in the teleconference, please dial +1 (877) 883-0383 [+1 (412) 317-6061 outside the U.S., Puerto Rico and Canada] and enter access code 7353716 approximately 15 minutes before the scheduled start of the call. The conference call will also be accessible live via webcast on the In

    3/3/26 6:59:00 AM ET
    $ACN
    Real Estate

    $ACN
    $APYX
    $CURI
    $LU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lufax Holding Ltd

    SC 13D/A - Lufax Holding Ltd (0001816007) (Subject)

    12/9/24 6:12:27 AM ET
    $LU
    Finance: Consumer Services
    Finance

    SEC Form SC 13G filed by Apyx Medical Corporation

    SC 13G - Apyx Medical Corp (0000719135) (Subject)

    10/31/24 5:44:01 PM ET
    $APYX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Apyx Medical Corporation

    SC 13G/A - Apyx Medical Corp (0000719135) (Subject)

    10/15/24 9:18:53 AM ET
    $APYX
    Medical/Dental Instruments
    Health Care